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Abstract
Background: Unilateral vestibular deafferentation results in strong microglial and astroglial activation in the
vestibular nuclei (VN) that could be due to an inflammatory response. This study was aimed at determining if
markers of inflammation are upregulated in the VN after chemical unilateral labyrinthectomy (UL) in the rat, and if
the inflammatory response, if any, induces the expression of neuroprotective factors that could promote the
plasticity mechanisms involved in the vestibular compensation process. The expressions of inflammatory and
neuroprotective factors after chemical or mechanical UL were also compared to verify that the inflammatory
response was not due to the toxicity of sodium arsanilate.
Methods: Immunohistological investigations combined the labeling of tumor necrosis factor a (TNFa), as a marker
of the VN inflammatory response, and of nuclear transcription factor B (NFB) and manganese superoxide
dismutase (MnSOD), as markers of neuroprotection that could be expressed in the VN because of inflammation.
Immunoreactivity (Ir) of the VN cells was quantified in the VN complex of rats. Behavioral investigations were
performed to assess the functional recovery process, including both static (support surface) and dynamic (air-
righting and landing reflexes) postural tests.
Results: Chemical UL (arsanilate transtympanic injection) induced a significant increase in the number of TNFa-Ir
cells in the medial and inferior VN on both sides. These changes were detectable as early as 4 h after vestibular
lesion, persisted at 1 day, and regained nearly normal values at 3 days. The early increase in TNFa expression was
followed by a slightly delayed upregulation of NFB 8 h after chemical UL, peaking at 1 day, and regaining control
values 3 days later. By contrast, upregulation of MnSOD was more strongly delayed (1 day), with a peak at 3 days,
and a return to control values at 15 days. Similar changes of TNFa,N F B, and MnSOD expression were found in
rats submitted to mechanical UL. Behavioral observations showed strong posturo-locomotor deficits early after
chemical UL (1 day) and a complete functional recovery 6 weeks later.
Conclusions: Our results suggest that the upregulation of inflammatory and neuroprotective factors after vestibular
deafferentation in the VN may constitute a favorable neuronal environment for the vestibular compensation
process.
Background
Vestibular compensation, i.e. functional recovery after a
unilateral lesion of the peripheral vestibular system, is a
good model to study the cellular and molecular
mechanisms involved in the neuroplasticity of the adult
central nervous system. Unilateral loss of vestibular
inputs to the brainstem vestibular nuclei (VN) is caused
by lesioning the peripheral sensory receptors (chemical
or mechanical unilateral labyrinthectomy, UL) or unilat-
erally transecting the vestibular nerve (UVN). These
procedures produce a complex vestibular syndrome
made of static and dynamic signs. The static signs
include postural deficits (increased support surface, head
tilt) and ocular motor deficits (spontaneous nystagmus)
that are compensated within a few days or weeks,
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deafferentation. Recent findings in the cat indicated that
vestibular deficits resulting from a functional deafferen-
tation are compensated faster (2 weeks after mechanical
UL) than those induced by an anatomical deafferenta-
tion (about 2 months after UVN) [1]. On the contrary,
the dynamic signs (vestibulo-ocular reflex asymmetry,
postural instability and equilibrium) are compensated
much less completely or over a longer time [2,3].
Several hypotheses have been proposed to explain the
vestibular compensation process [2,4]. At least part of
the behavioral recovery process has been attributed to
plasticity of neuronal and non-neuronal elements in the
deafferented VN. In line, recent findings have demon-
strated reactive neurogenesis in the adult cat [5,6] and a
strong microglial and astroglial reaction [5,7-9] after
unilateral deafferentation in the deafferented VN. Cam-
pos-Torres et al. [9] suggested that the glial reaction
may be due to modifications of the environment of VN
neurons and most probably to the central inflammatory
tissue reaction consecutive to UL. Despite this inflam-
matory reaction, the central vestibular neurons did not
show any sign of apoptosis after the permanent loss of
their peripheral inputs [8]. Glial reaction in the vestibu-
lar nuclei may be a beneficial mechanism. It could both
protect the injured tissue from long-lasting inflamma-
tion and promote the survival of deafferented vestibular
neurons [9] or of newly generated neurons [6]. Finally,
the inflammatory reaction could help in the vestibular
compensation process.
Upon insult or infection, the brain inflammatory
response generally involves the production of proinflam-
matory cytokines such as tumor necrosis factor a (TNFa),
interleukins (IL1b, IL-6...), interferon gamma (IFN-g), and
various reactive oxygen and nitrogen species [10]. To date,
the cellular inflammatory mediators produced by central
vestibular glial cells and/or neurons after peripheral vestib-
ular loss have not been characterized.
Among the inflammatory mediators, TNFa is a pro-
minent effector of the immune response in the brain. It
is constitutively expressed by astrocytes, microglia, and
neurons in the normal brain [11] and upregulated fol-
lowing various manifestations of brain injury, including
neurodegenerative disorders (Alzheimer’s and Parkin-
son’s diseases, multiple sclerosis), brain trauma, and
ischemic injury (for review, see [12]). It has been sug-
gested TNFa may thus have a pathogenic role in these
disorders. Nevertheless, TNFa has been shown to exert
both neurotoxic and neuroprotective effects in experi-
mental models. TNFa can mediate cell death [13,14]
but, conversely, TNFa is thought to enhance neuropro-
tective processes in models of acute neurodegeneration
(ischemia, excitotoxicity, axotomy) and chronic (Alzhei-
mer’s disease) neurodegeneration [15-20].
Increased levels of TNFa protect cells against damage
from cytotoxic insults in part via the induction of cyto-
protective genes, including Manganese Superoxide Dis-
mutase (MnSOD) [21-23]. The antioxidant enzyme
MnSOD is critical for neuronal survival in various para-
digms of stress-induced brain injury [23-26]. Xu et al.
[27] demonstrated that the presence of an intronic
nuclear factor B( N F B) site in the MnSOD gene was
essential for the induction of MnSOD by TNFa.N F B
is a nuclear transcription factor that has a protective
role in many tissues in response to stress, inflammation,
and immunity. NFB protects neurons from toxic
insults and promotes neuronal growth and synaptic
plasticity [24,28-30]. Widera et al. [31] demonstrated
that NFB plays a crucial role in the proliferation of
neural stem cells induced by TNFa.
The present study aimed to determine whether a che-
mical UL (transtympanic injection of sodium arsanilate)
inflicts an inflammatory response in the vestibular
nuclei. This reaction could be expressed by an increased
production of proinflammatory cytokines such as TNFa
and could induce a compensatory change in the expres-
sion of the neuroprotective factors NFBa n dM n S O D
during the course of the vestibular recovery. This was
achieved using immunohistochemistry, notably by quan-
tifying modulation of TNFa,N F B, and MnSOD label-
ing in the four main ipsilateral and contralateral VN
(medial, superior, lateral, and inferior). The immunohis-
tochemical data were recorded in groups of rats killed
4 h, 8 h, 1 day, 3 days, 7 days, and 15 days after chemi-
cal UL. In addition, functional recovery after chemical
UL was tested in another group of rats.
TNFa,N F B, and MnSOD labeling was also quanti-
fied in the ipsilateral and contralateral medial (MVN)
and inferior (IVN) nuclei in groups of rats submitted to
mechanical UL and sacrificed 8 h, 1, and 7 days after
the lesion. Effects of mechanical and chemical UL were
compared to ensure that arsanilate-induced changes in
the expression of inflammatory and neuroprotective fac-
tors were not due to the toxicity of arsanilate on brain-
stem structures.
Methods
Animals care and housing
The experiments were performed on male adult Long
Evans rats (300-350 g) obtained from R. Janvier (Le
Genest-St-Isle, France). Animals were maintained on a
12 h light/dark cycle at a constant temperature (22°C)
with ad libitum access to food and water. The experi-
ments were performed in accordance with the require-
ments of the French “Ministère de l’Agriculture et de la
Pêche” Décret no. 87-848, October 19, 1987 and to the
European Communities Council Directive of November
24, 1986 (86/609/EEC). Every attempt was made to
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used in these experiments.
Vestibular lesions
Chemical UL was produced by a unilateral transtympa-
nic injection of the toxin, sodium arsanilate. Sodium
arsanilate (Sigma, St Louis, MO) was dissolved in 0.3 M
sodium carbonate at the concentration of 300 mg/ml
and titrated to pH 7.5.
The rats were anesthetized with an intramuscular
injection of a solution of ketamine (Ketamine 1000, Vir-
bac, Carros, France, 62.5 mg/kg) and medetomidine
( D o m i t o r ,O r i o nP h a r m a ,E s p o o ,F i n l a n d ,0 . 4m g / k g ) .
Guided through a dissecting microscope, a 26-gauge
needle of injection was advanced through the tympanic
membrane, and 100 μl of sodium arsanilate was infused
in the left middle-ear. After the injection needle was
withdrawn, the external ear canal was packed with ster-
ile hemostatic sponge to prevent leakage of the toxin
away from the injection site. When the surgery was
completed, the effects of medetomidine were reversed
by a subcutaneous injection of the specific antagonist
atipamezole (0.33 mg/kg) (Pfizer, Paris, France). Using
this protocol, the effects of anesthesia were rapidly
reversed and, a few minutes later, the UL rats were able
to stand and thereafter to behave nearly normally.
The mechanical UL was performed using a retroauri-
c u l a ra p p r o a c h .T h ee n t i r el e n g t ho ft h ev e n t r a le d g eo f
the left meatus was destroyed. The tympanic membrane,
malleus, incus, and the stapes were removed to expose
the pterygopalatine. This artery was coagulated using an
electrocoagulator and the oval window was opened.
Finally, the vestibule was drilled and aspirated using a
suction tube. A postoperative i.m Terramycin (Pfizer,
Paris, France) injection was given to prevent infection.
Histological preparation
Thirty rats were subjected to a chemical UL. They
received unilateral transtympanic injection of sodium
arsanilate on the left side and were killed at six recovery
times after vestibular lesion: 4 h (n = 5), 8 h (n = 5),
1 day (n = 5), 3 days (n = 5), 7 days (n = 5), 15 days (n
= 5). Sham-operated rats (n = 24, four rats per group)
received a unilateral transtympanic injection of 0.9%
sterile saline and were killed at the same recovery time
as lesioned animals.
Six rats were submitted to mechanical UL on the left
side. Based on data recorded in the chemical UL rats,
they were killed at three recovery times: 8 h (n = 2),
1 day (n = 2), 7 days (n = 2).
Rats were deeply anesthetized with sodium pentobar-
bital (100 mg/kg IP) and perfused intracardiacally with
100 ml of 0.9% saline followed by 400 ml of 4% parafor-
maldehyde (Sigma, St Louis, MO) in 0.1 M phosphate
buffer (PB), pH 7.4. The brains were rapidly removed
and postfixed in a 4% paraformaldehyde solution for
24 h, cryoprotected by successive transfers into increas-
ing concentrations (10%, 20%, and 30%) of sucrose solu-
tion in 0.1 M PB for 72 h at 4°C. Brains were then
rapidly frozen on powdered dry ice (CO2 gas) and kept
at -80°C until use. They were sectioned coronally at 30
μm on a cryostat, and the sections were stored into
stock solution (0.1 M PB (pH 7.4), 30% (v/v) glycerol
and 30% (v/v) ethylene glycol) at -20°C until immuno-
histochemistry experiments.
Immunohistochemistry (IHC)
Free-floating sections were rinsed three times with 0.1
M phosphate buffer saline (PBS) for 5 min, preincubated
in a PBS 0.1 M solution containing 0.25% Triton X-100
and 10% bovine serum albumin (BSA) for 1 h at room
temperature. Thereafter, sections were incubated under
continuous agitation 24 h at 4°C in either a goat poly-
clonal TNFa antibody (1:200), a rabbit polyclonal NFB
antibody (1:200), or a rabbit monoclonal MnSOD anti-
body (1:200), diluted in a PBS 0.1 M solution containing
0.25% Triton X-100 and 2% BSA. The antibodies for
TNFa and NFB were obtained from Santa Cruz Bio-
technology (Santa Cruz, CA), anti-MnSOD from Epi-
tomic (Burlingame, CA).
On the following day, sections were washed 3 × 5 min
in PBS 0.1 M, BSA 2% and 3 × 5 min in PBS 0.1 M, BSA
5%. Then, they were incubated in 1:200 biotinylated sec-
ondary antibody diluted in PBS 0.1 M, 2% BSA for 1 h at
room temperature. Sections then underwent another
round of washing with PBS 0.1 M, BSA 2% (3 × 5 min)
and with PBS 0.1 M, BSA 5% (3 × 5 min) and were incu-
bated in biotinylated horseradish peroxidase avidin (Vec-
tor Laboratories, Burlingame, CA) for 1 h at room
temperature. Finally, for visualization, sections were
reacted using 0.2 mg/ml diaminobenzidine and 0.03%
hydrogen peroxide in PBS 0.1 M. After being washed
with PB, the sections were mounted on microscope slides
and allowed to dry overnight. The following day, sections
were dehydrated in ascending series of alcohol concen-
trations (70%, 80%, 90%, and 100%), cleared with xylene,
and coverslipped with DPX mounting media.
Immunolabeling for TNFa,N F B, and MnSOD was
examined 4 h, 8 h, 1, 3, 7 and 15 days after chemical
UL, and 8 h, 1 and 7 days after mechanical UL. The
specificity of the immunolabeling was validated by omis-
sion of the primary antibody. No labeling was observed
in these control conditions.
Data quantification of TNFa,N F B, and MnSOD
immunoreactivity in the vestibular nuclei
The vestibular nuclei were identified according to Paxi-
nos and Watson’s stereotaxic atlas of the rat [32].
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hereinafter MVN, SVN, LVN, and IVN respectively)
were easily differentiated without counterstaining. Data
quantification in the MVN, SVN, LVN, and IVN was
done in serial sections collected from the rostral (-9.96
mm) to the caudal (-11.76 mm) part of the brainstem.
Stained cells were counted in the MVN (27 sections per
rat), SVN (24 sections), LVN (15 sections), and IVN (24
sections). The variable number of sections depended on
the rostrocaudal extent of the nuclei [5]. The immunor-
eactivity quantification was performed on both sides.
The number of cells expressing TNFa,N F B, or MnSOD
was quantified via computer-assisted image analysis using a
DMLB microscope (Leica Microsystems, Wetzlar, Ger-
many) equipped with a DXM 1200 Nikon high-resolution
digital camera (1024-1024 pixels; Nikon, Tokyo, Japan)
interfaced to a PC computer employing image software for
capturing and processing the images (Lucia G, Nikon,
Champigny-sur-Marne, France). Quantification of the
labeled cells was performed via a grey-level method by
adjusting a threshold brightness value, and only cells labeled
with a grey value above this threshold were taken into
account. Reproducibility was assessed by comparing the
same data analyzed independently by two researchers blind
to the animal groups. Specific labeling was quantified in
each section as the number of labeled cells and was auto-
matically computed and expressed as the mean (± SEM) for
each side, each rat, and each subgroup of rats [5]. To elimi-
nate quantification problems due to potentially asymmetric
slides, data were collected from symmetrical slides only.
The absence of structural asymmetry in the slides was veri-
fied on slides stained with cresyl violet.
Behavioral investigations
Behavioral investigations were performed in another
group of rats (n = 6) to assess static and dynamic pos-
tural deficits after arsanilate lesion and the time course
of the functional recovery.
Static postural deficits and recovery were evaluated by
measuring the surface delimited by the four legs of the
rat standing erect at rest, without walking. Support sur-
face is a very sensitive parameter used for evaluating ves-
tibular lesion-induced static posture deficit and recovery.
To quantify the support surface, the rats were placed in a
box equipped with a transparent bottom and filmed from
under this box. A scale drawn on the bottom served to
take measurements of the four paws location. Four
repeated measurements were taken for each rat before
chemical UL, and at regular intervals during the course
of recovery until complete recovery (60 days). The sup-
port surface was measured using an image analysis sys-
tem (Canvas 9TM, Deneba Software, Miami, FL). An
average was calculated for each postlesion time. Data
recorded after vestibular lesions were compared to the
mean prelesion values using individual references, that is,
each animal acted as its own control.
Dynamic postural deficits and recovery were evaluated
in the same group of rats (n = 6) using two dynamic
reflex tests, the air-righting reflex and the landing reflex.
The air-righting reflex was used to test the rat’sa b i l i t y
to right itself in the air, while the landing reflex was
used to test the response of the rat to a vertical linear
acceleration. The tests were considered to evaluate the
level of the vestibular deficit and of the recovery process
following the vestibular lesion.
During the air-righting test, the rats were held at
50 cm above a cushion, in supine position. The experi-
menter removed his/her hands as quickly and simulta-
neously as possible. In a normal rat, just after the drop,
the vestibular system detects a change in linear accelera-
tion that triggers the head turning, which in turn
induces the sequence of body repositioning. After ves-
tibular lesion, the righting response is totally abolished
and it recovers with time through the vestibular com-
pensation process. A score of “0” was assigned when the
air-righting reflex was complete, “2” when the animal
failed to return itself and fell on its back, and “1” when
it showed a partial reaction only.
During the landing reflex, the rats were held by the
base of the tail and lowered toward the ground. Animals
with intact vestibular function flex their neck and
extend their forelimbs as they approach the surface,
whereas rats with vestibular lesion at an uncompensated
stage show the right response only when their forepaws
or vibrissae touch the ground. A score of “0” was
assigned when the animals responded properly, and “2”
if ground contact was required.
T h es c o r e sf o rt h ea i r - r i g h t i n gr e f l e xa n dt h el a n d i n g
reflex were summed, providing a global score of
dynamic vestibular function and recovery. A zero score
indicated a normal vestibular function as observed
before the vestibular lesion, or a complete recovery after
U L .S c o r e sr a n g i n gf r o m1t o4p o i n t e dt ov e s t i b u l a r
dysfunction and more or less complete vestibular com-
pensation. Three repeated measurements were taken for
statokinetic tests for each rat before chemical UL and at
each postoperative time. A mean was calculated for
each postlesion time and compared to the mean prele-
sion values. As for the support surface evaluation, each
animal acted as its own control.
For some experimental animals, double-blind quantifi-
cation was performed for the dynamic reflex tests,
which did not show any dependence on the experimen-
tator when he/she was trained to perform the tests.
Statistical analysis
TNFa,N F B, and MnSOD immunolabeling in the VN
observed after a chemical UL was analyzed using
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lesion (sham vs arsanilate-lesioned rats) and postopera-
t i v er e c o v e r yp e r i o d( 4 ,8h ,a n d1 ,3 ,7 ,1 5d a y s )a s
between-factors, and with the nuclei (MVN, SVN, LVN
and IVN) as within factors. When a significant differ-
ence was revealed, Student’st - t e s t sw e r eu s e df o r
further two by two comparisons between sham and
lesioned animals at the six postoperative times. The
levels of significance were set at p < 0.01 (TNFa and
NFB) and p < 0.0083 (MnSOD) according to the num-
ber of multiple comparisons (ie, Bonferroni’s principle).
TNFa,N F B, and MnSOD immunolabeling in the
MVN and IVN after mechanical and chemical UL was
analyzed using repeated-measures ANOVA with type of
lesion (mechanical vs chemical UL) and postoperative
time (8 h, 1 and 7 days) as between-factors, and with
the vestibular nuclei (MVN and IVN) as within factors.
Unpaired t-tests were used for comparisons between
mechanical and chemical UL animals at the three post-
operative times. The levels of significance were set at p
<0 . 0 1 6( T N F a,N F B, and MnSOD) according to the
Bonferroni’s principle.
Support surface values at each postoperative time were
compared with preoperative surface values for each rat
by a paired Student’s t-test. The global score of the rats
in the air-righting and landing reflex tests recorded at
each postoperative time was compared to the preopera-
tive performance of each rat by a paired Student’s t-test.
The levels of significance were set at p < 0.0038 (sup-
port surface and global score) according to the number
of multiple comparaisons (Bonferroni’s principle).
Results
1. Immunohistochemical data
Chemical UL-induced change in TNFa immunoreactivity in
the vestibular nuclei
Repeated-measures ANOVA of the cell counts of
TNFa-positive cells demonstrated that the lesion (p <
0.0001), the structure (MVN, SVN, LVN and IVN) (p <
0.0001), and the postoperative time (4 h, 8 h, 1, 3, 7 and
15 days) (p < 0.05) constituted the main fixed effects
providing the sources of variation among animals. This
was also corroborated by the significant interaction
between these variables (p < 0.0001). In contrast, no sig-
nificant differences were found between the ipsilateral
and contralateral VN for both the sham-operated and
the arsanilate-lesioned rats. Consequently, the data from
both sides were pooled and averaged for both groups of
rats.
Figure 1A illustrates the TNFa-Ir changes in the
MVN and the IVN of two representative rats: one
sham-operated rat and one arsanilate-lesioned rat killed
8 h after the vestibular lesion. Chemical UL resulted in
an increase in TNFa expression in the both VN, as seen
by the increased number of TNFa-Ir cells. This change
in TNFa expression was also observed in the SVN, but
not in the LVN.
Quantitative analysis of TNFa-like immunolabeling in
the MVN and the IVN is shown in Figure 1B. A signifi-
cantly increased number of labeled cells was first
detected 4 h following the lesion, but the highest signifi-
cant numbers of TNFa-positive cells were encountered
in the MVN (288.6 ± 11.9, p < 0.0001) and IVN (75.9 ±
1.2, p < 0.001) at the 8 h survival period. One day after
the lesion, TNFa-like immunoreactivity persisted signifi-
cantly (249.5 ± 25.4 (p < 0.01) and 69.4 ± 4.5 (p < 0.01)
for the MVN and IVN, respectively).
The mean number of TNFa-Ir cells regained normal
values three days after the lesion (173.8 ± 16.4 and 50.9
± 5.6, in the MVN and IVN respectively).
Chemical UL-induced change in NFB immunoreactivity in
the vestibular nuclei
Repeated-ANOVA revealed significant effects of the
lesion (p < 0.05) and an interaction between the lesion
and the postoperative time (p < 0.05). Data obtained in
the sham-operated groups at the different postoperative
times were pooled and considered as control values.
Figure 2 shows microphotographs of NFB-Ir sections
taken for the ipsilateral MVN and IVN from one repre-
sentative sham-operated rat and from one rat killed 1
day after the lesion. As observed with TNFa,t h en u m -
ber of NFB-Ir cells in both VN increased substantially
after arsanilate UL.
Quantitative analysis of the data is shown in Figure 3
for the MVN and the IVN, displayed here as representa-
tive nuclei of the VN complex. The average number of
NFB-Ir cells in the MVN and IVN was 177.1 ± 11.5
and 68.5 ± 5.9, respectively, in the controls. A significant
bilateral increase was first observed 8 h postlesion in the
MVN (258.2 ± 30.6, p < 0.01) and remained unchanged
at 1 day (267.3 ± 37.9 for MVN, p < 0.01). Three days
after arsanilate lesion, the mean number of NFB-Ir
cells tend to return to control values in the MVN (244.6
± 32.0). The same time-course was observed in the IVN,
even tough it remained just below the level of signifi-
cance (p = 0.03 and p = 0.02 at 8 h and 1 day
respectively).
Chemical UL-induced change in MnSOD immunoreactivity
in the vestibular nuclei
Repeated-ANOVA revealed significant effects of the
lesion (p < 0.001), the structure (p < 0.0001), and the
postoperative time (p < 0.01); it also showed that
the interaction between these factors (p < 0.05) was sig-
nificant. As for NFB quantification, data obtained in
the sham-operated group at the different postoperative
times were pooled and expressed as control values.
Arsanilate UL resulted in an increase in MnSOD
expression in the bilateral VN. An illustration of this
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Figure 1 Chemical UL-induced changes of TNFa-Ir cells in the MVN and IVN. (A) Illustration of the typical labeling in a representative sham
rat and in an experimental animal subjected to chemical UL (arsanilate transtympanic injection) observed 8 h after the lesion. Note that
chemical UL induces an increased number of TNFa-Ir cells. Scare bar: 100 μm. (B) Quantitative analysis of the effects of chemical UL on TNFa-Ir
cells in the MVN and IVN. Data are mean values (± SEM) of the number of TNFa-Ir recorded in the sham rats (black histograms) and in the UL
rats (grey histograms) observed at 4, 8 h, 1, 3, 7, and 15 days after the lesion. The data from both sides were pooled for sham and experimental
animals. According to Bonferroni’s principle, P < 0.01 was considered significant. * P < 0.01, ** P < 0.001, *** P < 0.0001 versus sham values
(MVN: medial vestibular nucleus; IVN: inferior vestibular nucleus).
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Figure 2 Illustration of the NFKB immunostaining in the MVN and IVN in a sham rat and in a rat subjected to chemical UL, killed one
day after the lesion. The number of NFB-Ir cells increased in the MVN and IVN of the UL rat. Scare bar: 100 μm.
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Figure 3 Quantitative analysis of the effects of chemical UL on NFKB-Ir cells in the MVN and IVN. Data are mean values (± SEM) of the
number of NFB-Ir cells in the MVN and IVN for rats that had chemical UL and observed at 4, 8 h, 1, 3, 7, and 15 days after the lesion. Data of
all postoperative times were pooled in sham animals, and mean value is shown as a horizontal line and standard error of the mean (± SEM) as
two dotted lines. According to Bonferroni’s principle, P < 0.01 was considered significant. * P < 0.01 versus sham values.
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shown in Figure 4A. This change of MnSOD expression
was also observed in the SVN but not in the LVN.
Figure 4B illustrates the quantitative analysis of these
data in the MVN and the IVN. Compared to controls,
which exhibited a mean number of MnSOD-Ir cells of
86.6 ± 3.7 for the MVN and 37.9 ± 0.8 for IVN, the 1
day postlesion group displayed an increase in MnSOD-
labeled cells with a mean number of 127.6 ± 6.1 and
52.8 ± 0.6 for the MVN and IVN respectively (p <
0.00083). The number of MnSOD-Ir cells continued to
increase at 3 days postlesion (170.2 ± 13.4 and 60.6 ±
2.4 for the MVN (p < 0.00083) and for the IVN (p <
0.00083) respectively), and remained unchanged in the
MVN at 7 days (167.9 ± 17.3, p < 0.00083). Fifteen days
after arsanilate UL, normal values were recorded in the
MVN (96.4 ± 7.0) and the IVN (42.6 ± 2.9).
Upregulation of TNFa,N F B, and MnSOD expression after
chemical and mechanical UL
Repeated ANOVA of the cell counts of TNFa,N F B, or
MnSOD-positive cells revealed no significant effect of
the type of lesion (chemical vs mechanical) and no sig-
nificant interaction between the lesion and the post-
operative time for all the markers. No significant
differences were found between the ipsilateral and con-
tralateral MVN and IVN of mechanical UL rats at the
different postoperative times. Consequently, data from
both sides were pooled and averaged for each group of
mechanical UL rats.
Quantitative analysis of TNFa,N F B, or MnSOD
immunolabeling in the MVN and IVN after mechanical
and chemical UL is shown in Figure 5. Whatever the
postoperative times, the mean values in the mechanical
UL rats did not differ significantly from those of the
chemical UL rats (Figure 5).
For the TNFa-positive cells, the mean numbers
recorded in the 8 h postoperative group were 288.6 ±
11.9 and 218.5 ± 6.7 in the MVN for the chemical and
mechanical UL rats, respectively (NS). A similar upregu-
lation of TNFa-Ir cells was observed with both types of
lesions at the 1 day survival period in the MVN (Figure
5A). Similar changes were found in the IVN when con-
sidering the chemical and mechanical groups of rats
(Figure 5A), and when considering the NFB-positive
cells (Figure 5B) as well as the MnSOD-positive cells
(Figure 5C) in both the MVN and IVN. Only one signif-
icant difference (p < 0.016) was seen for the MnSOD-
positive cells in the IVN at the 1 day survival period, in
favor of the mechanical UL group. In addition, return
towards normal values was similar for the three markers
considered in the present study in both the chemical
and mechanical UL rats, indicating a similar time-course
of upregulation in both models of unilateral vestibular
deafferentation.
2. Behavioral investigations
Behavioral observations
Unilateral inner ear injection of arsanilate induced the
typical behavioral signs of vestibular deafferentation. All
arsanilate-UL animals exhibited characteristic oculomo-
tor nystagmus with slow phase directed toward the
lesioned side and fast phase beating toward the contral-
ateral side. The postural and locomotor symptoms con-
sisted of rolling and circling behaviors, head tilt and
falls toward the lesioned side, and postural asymmetry
with strong enhancement of the support surface.
Recovery of static posture function
Recovery of static posture function after arsanilate-UL
was evaluated by measuring the support surface delim-
ited by the four legs of the rat standing erect at rest.
Figure 6 shows the time-course of posture function
recovery after vestibular lesion. The support surface was
rather small in normal rats (20.2 ± 1.0 cm
2) and greatly
increased in the days following the vestibular lesion.
Maximal support surface increase (50.1 ± 1.1, p <
0.00038) was observed 1 day postlesion, resulting from a
strong hypotonia of the limb extensors ipsilateral to the
lesion and strong hypertonia of the contralateral exten-
sors muscles. The support surface decreased progres-
sively during the following days but remained superior
to preoperative values on the 8
th postoperative day (38.6
± 1.5, p < 0.00038). At 30 days postlesion, the support
surface remained significantly larger (27.0 ± 1.2, p <
0.0038). The complete compensation of this postural
parameter required 36 days.
Recovery of dynamic posture function
Before vestibular lesion, all animals had the ability to
right themselves when they were held in a supine posi-
tion and dropped in the air. The animals also succeeded
in flexing their neck and extending their forelimbs when
they were lowered toward the ground. The air-righting
and the landing reflexes were normal in these controls
and the global score was zero.
After arsanilate-UL, rats failed to succeed in either
test. Figure 7 shows the mean time-course of recovery.
One day after the lesion, the mean global score of the
UL rats was 2.3 ± 0.2 (p < 0.00038), indicating that ani-
mals failed in performing correct body air-righting reflex
a n dl a n d i n gr e f l e x .F r o md a y2t o8 ,t h em e a ng l o b a l
score remained significantly increased (2.9 ± 0.1, p <
0.00038) on day 8. Then, the UL rats’ deficits gradually
decreased over time and animals fully recovered both
air-righting reflex and landing reflex as correctly as nor-
mal rats 42 days after UL only.
Discussion
The present study shows first that a chemical UL
induces the typical postural and locomotor symptoms
seen after all types of vestibular deafferentation and a
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requiring 5-6 weeks. Second, the present findings
demonstrate that chemical UL induces a rapid inflam-
matory reaction in the VN, as shown by the significantly
increased expression of the proinflammatory cytokine
TNFa.T h i sT N F a upregulation is followed by an
increased expression of the antioxidant enzyme
MnSOD, associated with the upregulation of the nuclear
transcription factor NFB. Similar changes of TNFa,
NFB, and MnSOD expression were found in rats sub-
mitted to mechanical UL. The changes in the expression
of neuroprotective factors could constitute a favorable
neuronal environment for the vestibular compensation
process.
1. Behavioral recovery after chemical UL
Unilateral transtympanic injection of sodium arsanilate
in the rat induces classical postural deficits (ipsilateral
head tilt, increased support surface with ipsilateral limb
flexion and contralateral limb extension) and locomotor
(ipsilateral falls, rolling and circling) deficits. However,
the complete recovery of these postural functions is
much longer than that reported in this species after
mechanical UL [9,33]. Indeed, head tilt and postural
asymmetry disappeared 3-4 days after mechanical UL
[9], while 6 weeks were required in the present study.
These differences in the time constant of the recovery
process were already reported by Kim et al. [34], who
showed head deviation peaking 2 h and 3 days after
mechanical UL and chemical UL, respectively. In addi-
tion, these authors reported a head posture significantly
tilted during at least one week after chemical UL since
longer recovery delays were not tested in their study.
Interestingly, the unilateral section of the vestibular
nerve (UVN) in the cat model also induced a delayed
behavioral recovery (6 weeks) compared to mechanical
UL (2 weeks) [1]. Such differences in the recovery pro-
files can be accounted for by the nature of the VN deaf-
ferentation. There is a total, sudden, anatomical and
functional deafferentation after UVN whereas mechani-
cal UL leads to a partial and progressive anatomical
deafferentation [1,35]. And it was recently reported that
the plasticity mechanisms involved in the recovery pro-
cess also differ with the type of vestibular deafferenta-
tion [36].
A first explanatory hypothesis is that chemical UL is a
model of VN deafferentation that is closer to the UVN
model. Indeed, intratympanic injection of sodium arsani-
late has been shown to cause permanent loss of vestibu-
lar function as a result both of degeneration of the
vestibular sensory epithelium [37,38] and of the vestibu-
lar nerve [39]. This degeneration of the vestibular nerve
would explain why the recovery process is longer after
chemical UL than after mechanical UL. However, recent
findings in the adult rat submitted to chemical UL, simi-
lar to our protocol, clearly showed that the Scarpa’s
ganglion neurons, the vestibular nerve, and the brain-
stem structures did not exhibit any degeneration after
intratympanic injection of sodium arsanilate, from 3
days to 1 month after injection (Chabbert, personal
communication). The transtympanic injection targets on
epithelial vestibular sense organ (and on cochlear
epithelium) and toxicity of arsanilate were similar to
that of glutamate excito-toxicity [40]. In this case, the
differences between mechanical and chemical UL could
be in the postlesion discharge in the vestibular nerve.
No electrophysiological inputs to the vestibular nuclei
are seen just after mechanical UL while abnormal elec-
trophysiological action potentials could occur in the ves-
tibular nerve after arsanilate lesion, due to axonal
terminations still connected to hair cells. This hypoth-
esis is based on the observations of heterotopic electrical
discharges in the hair cells after glutamate excito-toxi-
city [40]. If confirmed, this hypothesis could explain the
longer recovery time-course after chemical UL than
mechanical UL in rodents.
2. Inflammatory and neuroprotective responses in the VN
after unilateral vestibular deafferentation
A massive microglial and astroglial reaction was
observed in the bilateral VN after mechanical UL in the
rat [8,9]. Moreover, axotomy or removal of the periph-
eral sensory hair cells failed to cause any neuronal cell
death in the VN [8]. Not only the second-order vestibu-
lar neurons do not degenerate, but these neuronal cells
recover a near normal resting discharge one week after
mechanical UL in the guinea-pig [41]. The reactive glio-
sis observed in the VN could be therefore a beneficial
mechanism protecting the injured nervous tissue. As
suggested by Campos-Torres et al. [9] and described in
other nerve injury paradigms [42,43], pro- and anti-
inflammatory cytokines produced by activated glial cells
could promote the survival of deafferented vestibular
neurons and therefore may contribute to the vestibular
compensation process.
Chemical UL-induced upregulation of TNFa in the VN
Our findings clearly showed a significant increase in the
proinflammatory cytokine TNFa in the bilateral VN,
detectable as early as 4 h after UL and persisting until 3
days. TNFa is expressed by neurons, in addition to glial
cells, in the normal brain, and TNFa receptors are pre-
sent on all neural cell types, rendering the cells respon-
sive to TNFa signaling [11]. TNFa is upregulated in
several neurodegenerative disorders (cerebral malaria,
AIDS dementia, Alzheimer’sd i s e a s e )a n dh a sb e e np r i -
marily considered to promote the pathologies [44-46].
B e s i d e st h i sp o t e n t i a ln e u r o t oxic effect, numerous stu-
dies have revealed an unexpected role of TNFa in CNS
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oxide-induced injury [18,20], and glutamate [17,19,47]
or b amyloid neurotoxicity [15,23], in part by induction
of antioxidant pathway [15]. Neuronal damage after
focal cerebral ischemia or administration of kainic acid
is increased in mice lacking TNFa receptor [48]. After
optic nerve axotomy, TNFa was found to prevent sec-
ondary death of the retinal ganglion cells [16]. Such a
neuroprotective effect of TNFa could promote the sur-
vival of both the present VN neurons (no cell death)
and the newly generated neurons found in the deaffer-
ented VN after UVN in the cat [5,6]. The wide variety
of responses to TNFa, including apoptosis as well as
cell survival and cell proliferation, can be in part
explained by signaling pathways mediated through dif-
ferent TNF receptors (TNFR). TNFR1 contains an intra-
cellular “death domain” associated with the detrimental
effects of TNFa in models of acute neurodegeneration
[13,49,50] while TNFR2 would contribute to cell survi-
val, growth, and proliferation [13,17,51-53].
Chemical UL-induced upregulation of NFB in the VN
NFB is a transcription factor activated after brain ische-
mia [54] and spinal cord injury [55,56] and in neurode-
generative processes [57]. However, like TNFa,N F B
also has a neuroprotective role. Preactivation of NFBb y
ceramide or by low amounts of TNFa protects neurons
from glutamate ototoxicity or oxidative insults [58].
NFB activation mediates the anti-death action of TNFa
in hippocampal neurons exposed to hypoxia or b amyloid
toxicity [15,24,28]. Such a TNFa-induced NFB activa-
tion could play a similar neuroprotective action after che-
mical UL. Indeed, our results showed that NFBw a s
upregulated in the bilateral VN shortly after the upregu-
lation of TNFa. In cortical neurons exposed to glutamate
toxicity, the signaling pathways involve TNFR1 and
TNFR2 [17]. While activation of the TNFR1 pathway
leads to a transient NFB upregulation (30 min), TNFR2
signaling promotes persistent and long lasting NFB acti-
vation (up to 24 h) [17]. These authors suggested that the
duration of NFB activation was critical to achieve signif-
icant tissue protection. Since NFBw a su p r e g u l a t e di n
the VN up to 20 h after onset of TNFa upregulation, we
hypothesize that TNFa could act through TNFR2 to acti-
vate neuroprotective signaling pathways involved in the
recovery process after chemical UL.
Chemical UL-induced upregulation of MnSOD in the VN
A delayed and long lasting upregulation of MnSOD was
shown also in the bilateral VN after chemical UL. These
changes were detectable 1 day after arsanilate injection
and persisted up to 7 days. MnSOD is regulated tran-
scriptionally and induced by inflammatory cytokines,
including TNFa, IL1, and IFNg [59-61]. Yune et al. [22]
demonstrated that exogenous TNFa induces MnSOD
expression in the uninjured spinal cord, a process that is
inhibited after treatment with a TNFa antibody in
injured tissue.
Inflammatory cytokines like TNFa generate reactive
oxygen species (ROS), and the mitochondrial respiratory
chain is the main source of TNFa-induced ROS [62].
The cells contain a variety of antioxidant enzymes, such
as mitochondrial MnSOD, which defend against free
radicals damage. MnSOD protects cells against oxidative
stress by rapidly dismutating superoxide radicals (O2)t o
hydrogen peroxide (H2O2) [63]. Hydrogen peroxide can
be further detoxified into water and oxygen by catalase
or glutathione peroxidase [64]. Accumulating data indi-
cate that MnSOD is critical for neuronal survival against
various stress-induced brain injuries [25,65], and that
increased levels of TNFa in response to cytotoxic insults
protect neurons in part via the induction of cytoprotec-
tive genes, including MnSOD [22-24,26]. MnSOD pro-
tection has also been demonstrated in non-neuronal
cells [21,27,66].
Little is known, however, on the molecular mechanisms
that govern transcription of the MnSOD gene. NFBh a s
been proposed as one of the three transcription factors
(with AP-1 and C/EBP-b) regulating TNFa-induced
MnSOD expression in different cell types [21-23,62,66].
It is likely that MnSOD induction, found in the present
study in VN cells after chemical UL, is mediated through
activation of NFB. However, NFB and MnSOD expres-
sions showed different kinetics, with NFB peaking at 1
day postlesion while MnSOD expression peaked 3 days
postlesion, as previously reported after spinal cord injury
[22]. This suggests that other transcription factors could
be involved. Before being activated, NFBr e s i d e si nt h e
cytoplasm in an inactive form consisting of three subu-
nits: p50 and p65 (constituting the factor dimer p50-p65)
and the IB inhibitory subunit. When IB is bound to
p50-p65, NFB is inactive. Signals activating NFB
(TNFa: see [67]) cause dissociation of this complex,
releasing p50-p65 that then translocates to the nucleus
and binds to specific B DNA sequences in the promoter
region of a variety of NFB-responsive genes, such as
MnSOD gene. Xu et al. [27] found that induction of
MnSOD by TNFa required the presence of an intronic
nuclear factor B( N F B) site in the MnSOD gene. And
protection of neuronal cells from b-amyloid peptide toxi-
city by TNFa-induced MnSOD activation resulted from
an enhanced binding of the dimer p50-p65 to the promo-
ter/enhancer regions of the MnSOD gene [23]. The upre-
gulation of the neuroprotective MnSOD protein
observed in our chemical UL model could be due to acti-
vation of such a sequence.
Effects of chemical and mechanical UL on TNFa,N F B, and
MnSOD upregulation in the rat
Comparison of chemical and mechanical UL data
strongly suggests that the inflammatory response
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per se of sodium arsanilate on brainstem structures.
Since the amount as well the kinetics of the upregula-
tion of the three markers did not differ for the mechani-
cal UL group compared to the chemical UL group, this
suggests that the cellular response to vestibular deaffer-
entation is similar in both models.
These results are supported by Campos-Torres and
de Kazak’s personal observations, reported in the dis-
cussion of the paper by Campos-Torres et al., 2005 [9].
The authors studied cytokine expression within the
vestibular nuclei at different times after mechanical
labyrinthectomy in the rat. They reported that the real
time light cycler RT-PCR studies showed a significant
upregulation of TNFa and interleukin (IL1, IL-6)
within the vestibular nuclei beginning at 6 h after the
lesion.
Changes of TNFa,N F B and MnSOD protein in the bilateral
VN
Why the changes in all the markers (TNFa,N F B, and
MnSOD) can be seen bilaterally, given that the lesion
was unilateral, can be explained with respect to the
neural connectivity between the VN on both sides, and
to their cell content. Neuroanatomical studies have
shown that the VN neurons are under the control of
both excitatory inputs from the ipsilateral labyrinth and
inhibitory inputs from the contralateral labyrinth via
direct projections (commissural system) and indirect
ones (cerebellar cortex loops) [68]. It was also shown
that the VN contains different subpopulations of neu-
rons, including excitatory second order vestibular cells
(tonic and kinetic type I neurons), inhibitory second
order vestibular cells, excitatory interneurons, and inhi-
bitory interneurons (type II neurons), at least for the
MVN [69]. Vestibular deafferentation can therefore lead
to changes in different subpopulations of cells in the
VN on the intact and lesioned sides. Dysinhibitory and/
or dysfacilitatory processes can activate type I cells on
the intact side, as evidenced electrophysiologically [70],
whereas facilitatory processes can activate both excita-
tory and inhibitory interneurons on the lesioned side.
Such mechanisms can also explain the early bilateral
increase in c-Fos mRNA and Fos protein levels
observed in the MVN, SVN, and IVN after hemilabyr-
inthectomy in the rat [71]. Indeed, those authors
observed that the changes were asymmetric in the
MVN, being most prominent in the dorsal part of the
contralateral MVN (where second order vestibular neu-
rons are located) and in the ventral part of the ipsilat-
eral nucleus (where commissural neurons acting on the
MVN of the intact side are located). Many other works
also pointed out bilateral changes in the cat model for
c-Fos [72], choline acetyltransferase-Ir [73], and GABA-
Ir [[74], see 36 for a review].
Conclusions
Our study indicates that behavioral recovery after che-
mical UL in the rat is similar to that previously reported
in the cat model after UVN. We provide cellular evi-
dence that this type of vestibular deafferentation, as well
as mechanical UL, induces a strong inflammatory reac-
tion in the VN, as shown by the increased expression of
the proinflammatory cytokine TNFa. The compensatory
responses to this stress, that is, upregulation of the neu-
roprotective factors NFB and MnSOD, very likely con-
stitute a favorable environment 1) to prevent existing
VN cells from apoptosis, and 2) to promote the plasti-
city mechanisms involved in the recovery process,
including cell survival and cell differentiation of newly
generated cells. Indeed, the role of TNFa and NFBi n
cell proliferation and cell differentiation has been
strengthened by recent reports in both neonatal [75]
and adult [31,76] brain structures. The present findings
strongly suggest that proinflammatory cytokines and
induced neuroprotective factors play a role in the recov-
ery of vestibular functions.
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